PharmaRoth Labs, Inc. (ROTH)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
At close: Aug 11, 2026
PharmaRoth Labs Market Cap
PharmaRoth Labs has a market cap or net worth of $391 as of August 19, 2026.
Market Cap
391.00
Enterprise Value
n/a
Revenue
200.15K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since December 11, 2008, PharmaRoth Labs's market cap has decreased from 10.20M to 391.00, a decrease of -100.00%. That is a compound annual growth rate of -43.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 391.00 | - |
| Dec 27, 2024 | 391.00 | - |
| Dec 1, 2023 | 391.00 | -99.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Amarantus BioScience Holdings | 630.00 |
| Alzex Neuropharma | 602.00 |
| Adynxx | 581.00 |
| GlobeImmune | 575.00 |
| Mera Pharmaceuticals | 537.00 |
| Iterum Therapeutics | 528.00 |
| Tetra Bio-Pharma | 516.00 |
| Biora Therapeutics | 442.00 |